2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of female patients aged 65 years and olderContinue reading “2025 #50 MIPS Measure Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older”
CQMS Archive
2025 #48 MIPS Measure Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of Female Patients Aged 65 Years and Older Who Were AssessedContinue reading “2025 #48 MIPS Measure Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older”
2025 #47 MIPS Measure Advance Care Plan
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of Patients Aged 65 Years and Older WhoContinue reading “2025 #47 MIPS Measure Advance Care Plan”
2025 #39 MIPS Measure Screening for Osteoporosis for Women Aged 65-85 Years of Age
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of women 65-85 years of age who ever had a centralContinue reading “2025 #39 MIPS Measure Screening for Osteoporosis for Women Aged 65-85 Years of Age”
2025 #24 MIPS Measure Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of patients aged 50 years and older treatedContinue reading “2025 #24 MIPS Measure Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older”
2025 #8 MIPS Measure Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #8 MIPS Measure Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2025 #7 MIPS Measure Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #7 MIPS Measure Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)”
2025 #6 MIPS Measure Coronary Artery Disease (CAD): Antiplatelet Therapy
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #6 MIPS Measure Coronary Artery Disease (CAD): Antiplatelet Therapy”
2025 #5 MIPS Measure Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of Patients Aged 18 Years and Older with A Diagnosis ofContinue reading “2025 #5 MIPS Measure Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2025 #1 MIPS Measure Diabetes: Glycemic Status Assessment Greater Than 9%
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE:Intermediate Outcome – High Priority Description: Percentage of patients 18-75 years of age with diabetesContinue reading “2025 #1 MIPS Measure Diabetes: Glycemic Status Assessment Greater Than 9%”